Carbohydrate metabolism in menopausal women

Data on the worldwide prevalence of carbohydrate metabolism disturbances are reviewed. Pathogenesis of metabolic syndrome in menopausal women(menopausal metabolic syndrome) is considered, its clinical and laboratory characteristics are presented. Main therapeutic modalities (medicamenousand non-medicamentous) are discussed. Properties of the hypoglycemic drug metformin and indications to its use are described along with indicationsand contraindications to substitution hormonal therapy in women with metabolic disturbances